GT Biopharma Inc. Common Stock GTBP
$11.63
+35.08%
at last close
Market Cap$15.54 million
P/E Ratio—
Div Yield—
Volume524.3K
52-Week Range
$4.91$44.50
Key Stats
- Today's Range
- $8.65 – $11.98
- 50-Day Range
- $4.91 – $12.38
- 52-Week Range
- $4.91 – $44.50
- Volume
- 524K shs
- Average Volume
- 63K shs
- Market Cap
- $15.54 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 1.43%
- Days to Cover
- 1.00
About GT Biopharma Inc. Common Stock
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
Related Stocks
Compare head-to-head: GTBP vs LLY·GTBP vs JNJ·GTBP vs ABBV·GTBP vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.